Lipid–ASO therapeutics exhibit differential tissue targeted delivery upon systemic or local CNS administration
It is demonstrated that lipid identity critically determines ASO efficacy, productive cellular uptake, and regional CNS engagement, emphasizing the need for context-specific lipid design in ASO therapeutic development.